Dr Reddy's Labs launches Lansoprazole DR Orally Disintegrating Tablets in US
Hyderabad and Princeton: Dr. Reddy's Laboratories Ltd. today announced the launch of Lansoprazole DR Orally Disintegrating Tablets in US.
The product is a therapeutic equivalent generic version of Prevacid SoluTab Delayed- Release Orally Disintegrating Tablets, 15 mg and 30 mg, approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, committed to providing affordable and innovative medicines for healthier lives.
Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.